683 Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $1.26M | Sell |
|
|||||
|
2023
Q1 | $8.24M | Sell |
|
|||||
|
2022
Q4 | $14.5M | Sell |
|
|||||
|
2022
Q3 | $27.2M | Sell |
|
|||||
|
2022
Q2 | $30.4M | Hold |
|
|||||
|
2022
Q1 | $27.5M | Buy |
|
|||||
|
2021
Q4 | $30.5M | Buy |
|
|||||
|
2021
Q3 | $21.7M | Buy |
|
|||||
|
2021
Q2 | $18.6M | Buy |
|
|||||
|
2021
Q1 | $18.7M | Sell |
|
|||||
|
2020
Q4 | $22M | Buy |
|
|||||
|
2020
Q3 | $12.2M | Sell |
|
|||||
|
2020
Q2 | $15.1M | Buy |
|
|||||
|
2020
Q1 | $10.2M | Buy |
|
|||||
|
2019
Q4 | $8.12M | Sell |
|
|||||
|
2019
Q3 | $8.75M | Sell |
|
|||||
|
2019
Q2 | $15M | Buy |
|
|||||
|
2019
Q1 | $8.39M | Buy |
|
|||||
|
2018
Q4 | $5.98M | Buy |
|
|||||
|
2018
Q3 | $4.21M | Buy |
|
|||||
|
2018
Q2 | $2.63M | Buy |
|
|||||
|
2018
Q1 | $4.03M | Buy |
|